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Immunohistochemical evaluation of angiogenesis in warts
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Abstract
Objectives: Angiogenesis is a key event in tumour growth. An infection with human papillomavirus (HPV) typically leads to benign tumours, such as warts 
(papillomas) on the skin and mucous membranes. The role of angiogenesis in skin warts is yet to be established. 
Materials and methods: The present work evaluates the hypothesis that the development of skin warts is associated with alterations in the dermal vascularisation 
(dermal microvessel density/mm2, MVD). Seventeen cases of cutaneous warts and eight cases of normal skin were studied. Dermal vessels were immunostained for 
CD31, CD34 and CD105. The ten areas with the highest number of microvessels were counted. 
Results: The number of CD31+, CD34+ and CD105+ vessels was significantly higher in cutaneous warts compared to that in normal skin (mean ± SD: 45.71 ± 22.63 
vs 21.27 ± 5.83, P=0.0062; 59.75 ± 24.93 vs 17.13 ± 5.67, P<0.001; and 29.74 ± 7.09 vs 6.58 ± 1.89, P < 0.001 respectively). 
Conclusions: Higher MVD values in skin warts suggest a possible causal correlation between angiogenesis and development of papillomas in HPV infected skin. 
Our results shows the morphological histopathological explanation (high number of vessels) for the punk-shaped vessels seen in the dermatoscopical examination.
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Introduction
Skin warts are benign tumours caused by an Human Papilloma 
Virus (HPV) infection of the keratinocytes. HPV is a DNA virus 
belonging to the papillomavirus family which contains over 200 
genetically distinct strains. It infects the epithelia or the mucosa of the 
skin and mostly causes benign papillomas or skin warts [1]. Moreover, 
certain oncogenic HPV types 16, 18, 31, 33, 45, 52, and 58 may cause 
anogenital, oropharyngeal, and skin cancers, such as squamous cell 
carcinoma [2-3]. 
Although it is known that HPV plays a major role in the development 
of warts, the exact pathophysiological mechanism of tumour growth is 
still unclear. In all HPV infections, newly formed dilated blood vessels 
are present. In cutaneous warts, these vascular structures may be seen 
with the dermatoscope in form of multiple papillae containing a central 
red or punk-shaped black dot or loop surrounded by a whitish halo, 
also described as thrombosed capillaries [4]. Therefore angiogenesis 
and vasodilatation are considered to be involved in the development of 
warts [4-6]. Angiogenesis can be quantified by assessing the microvessel 
density (MVD), which reflects the number of vessels per mm2 within 
a histological section, and is associated with the degree of local 
neovascularisation [7]. Immunohistochemical endothelial markers 
such as CD31, CD34 and CD105 are used to identify endothelial cells 
and to detect local vascularisation [8,9]. 
CD31 (Platelet endothelial cell adhesion molecule, PECAM-1) 
is a single chain type-1 transmembrane protein that plays a role in 
endothelial cell-cell junctions, as well as leukocyte-endothelial cell 
junctions [10]. CD34 is also a single-chain transmembrane glycoprotein 
that is present in haematopoietic precursor cells and endothelial cells of 
blood and lymphatic vessels [11].
Endoglin (CD105) is an accessory receptor for transforming growth 
factor-beta (TGF-β), and its expression is up-regulated in actively 
proliferating endothelial cells. Endoglin is an appropriate marker for 
angiogenesis and neovascularisation [12-13].  
To date, the exact role of angiogenesis in skin warts has not 
been established. Therefore, the present work aimed to evaluate the 
immunohistochemical expression of CD31, CD34 and CD105 in 
common skin warts. We assume that these markers could be related to 
papilloma-dependent neoangiogenesis in HPV infected cells. 
Main text
Methods
Study population: Seventeen biopsies of histologically and 
clinically confirmed skin warts and eight biopsies of normal skin were 
included in the study to compare neoangiogenesis. The Inclusion 
criteria included samples of skin warts excised from the hands or 
feet of the patients who had not received any local medical treatment 
before the study. The medical history of all 25 patients was reviewed 
retrospectively focusing on age, sex, immune system status, and 
immunosuppressive medication use. The cantonal ethics commission 
of Bern approved the data analysis (KEK number 2018-00174).
Immunostaining and evaluation of CD31, CD34 and 
CD105: In order to compare the amount of dermal microvessels, 
immunohistochemical staining were performed using anti-CD31 
(Dako IS610), anti-CD34 (Leica PA0212) and anti-CD105 antibodies 
(MA5-11854). The stained samples were scanned using a Pannoramic 
MIDI slide scanner (3DHISTECH). Acquired images were analysed 
using Pannoramic Viewer 1.15.4 (3DHISTECH). In each section, a total 
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of 10 different fields with the highest number of microvessels in one 
flap section at 200x magnification were selected and the vessel number 
was independently counted by two staff members. Vascularity was 
quantified in the stroma close to the epithelium up to approximately 
500 μm from the basal cell layer. The vessel density was calculated as 
the number of vessels per square millimetre field, and the mean was 
reported for two groups. 
Statistical analysis
All analyses were conducted using the GraphPad Prism version 8.01 
(GraphPad Software, Inc. USA). Descriptive statistics were presented 
for the animals in mean  ±  SD. All p-values represent two-sided tests 
with an alpha level of 0.05. Mann Whitney test was used to detect the 
differences between groups. 
Results
Twenty five samples were used in this study, including seventeen 
skin warts and eight control samples. The mean age of the patients was 
52.91, and no significant difference was observed between the warts 
and control group with respect to age and sex. Nine patients (53%) 
in the warts group had undergone immunosuppressive therapy after 
organ transplantation. 
The immunostaining assay showed that CD31+, CD34+ and 
CD105+ vessel density was significantly higher in skin warts compared 
to that in normal skin, where the statistical data were represented as 
mean  ±  SD (45.71 ± 22.63 vs. 21.27 ± 5.83, p= 0.0062; 59.75 ± 24.93 vs. 
17.13 ± 5.67, p<0.001; 29.74 ± 7.09 vs. 6.58 ± 1.89, p<0.001; for CD 31 
and CD 34, CD105 respectively; (Figures 1 and 2).
Discussion
Angiogenesis plays a key role in primary tumour growth and 
can be quantified by the evaluation of the microvessel density, which 
reflects the number of vessels per mm2 within a histological section 
[6]. Vascular structures, spotted by dermatoscopy, are a characteristic 
clinical sign for the diagnosis of a skin wart [3]. However, the exact 
causative association of neovascularisation and the development of 
cutaneous warts remains unknown. CD31, CD34 are used as vascular 
endothelial markers, CD105 is helpful to assess neoangiogenesis. CD31 
and CD34 are expressed in numerous tumour vessels, but they are also 
positive in both normal vessels and activated vessels, whereas CD105 
has a higher affinity to activated endothelial cells [14-15]. Several 
previous studies have shown that CD 105+ vessels are newly formed 
and are fragile, they can easily tear and bleed [15-16].
Our results indicate that a higher MVD in skin warts suggests a 
possible link between angiogenesis and the development of papillomas 
in HPV-infected skin. Moreover, the presence of CD 105+ vessels could 
be the reason for the punk-shaped vessels visible dermatoscopically, 
which are also described by other authors as thrombosed capillary 
loops [4].
Conclusions
To our knowledge, this work is the first attempt to investigate 
the immunohistochemical detection of microvessels in skin warts. 
Figure 1A. CD 31+ vessels in the upper dermis (stained red) in a wart sample (×10 original 
magnification) 
Figure 1C. CD 105+ vessels in the upper dermis (stained red) in a wart sample (×10 original 
magnification)
Figure 2. Significantly higher CD31+, CD34+ and CD 105+ vessel density in skin warts 
compared to the normal skin. (* P- Value= 0.0062, ** P-Value < 0.0001)
Figure 1B. CD 34+ vessels in the upper dermis (stained red) in a wart sample (×10 original 
magnification)  
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Our results provide evidence of angiogenetic activity by using CD31, 
CD34 and CD105 immunohistochemistry in skin warts, and indicate 
that local microvasculature may undergo papilloma-dependent 
angiogenesis. Further research is needed to investigate the possible 
causative role of angiogenetic factors in the development of skin warts 
as well as their potential benefit as therapeutic targets in the treatment 
of this skin infections. 
Limitations
However, our study has several limitations. The data were 
analysed retrospectively, and the study population was rather small. 
In evaluating immunohistochemical results, there are possible causes 
for poor staining results, which can be unwanted background staining, 
artifactual staining or weak or absent staining. 
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